Catalyst Wire Dossier Catalyst Wire Dossier

VVN461

· VivaVision Biotech, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VVN461, covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis [Phase 3]

See pricing